DSC
GMED icon

Daytona Street Capital’s Globus Medical GMED Stock Holding History

Daytona Street Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
2,570
+2,500
+3,571% +$212K 0.15% 128
2026
Q1 		$6.13K Buy
+70
New +$6.28K ﹤0.01% 266

Other funds holding GMED

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Daytona Street Capital's GMED Position: Q2 2026 in Review

Daytona Street Capital increased its Globus Medical (GMED) stake by 3,571% in Q2 2026, buying an estimated $212K and bringing the position to 2,570 shares worth $201K. The position accounts for 0.15% of the portfolio, ranked #128.

Daytona Street Capital first reported a position in GMED in Q1 2026 and has held it in 2 quarters since. 278 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Daytona Street Capital held 2,570 shares of Globus Medical worth $201K as of Q2 2026.
  • Daytona Street Capital bought 2,500 Globus Medical shares in Q2 2026, an estimated $212K.
  • Globus Medical made up 0.15% of Daytona Street Capital's portfolio in Q2 2026, its #128 holding.
  • Daytona Street Capital first reported a position in Globus Medical in Q1 2026 and has held it in 2 quarters since.
  • 278 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Daytona Street Capital's 13F filing for Q2 2026, filed 3 Aug 2026.